Fund shareholders of IRLAB Therapeutics AB
ISIN SE0012675361 · Sweden
- Fund shareholders
- 10
- Of which ETFs
- 0 10 other funds
- Value held
- 2.1M SEK
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Handelsbanken Sverige Index Criteria Handelsbanken Fonder AB | 540,239 | 811.4K SEK | 0.00 % | as of Mar 31, 2026 ↗ |
| SEB Sverige Indexnära SEB Funds AB | 281,499 | 422.8K SEK | 0.00 % | as of Mar 31, 2026 ↗ |
| PLUS Mikrobolag Sverige Index ISEC Services AB | 239,722 | 360.1K SEK | 0.09 % | as of Mar 31, 2026 ↗ |
| SEB Sverige Indexfond SEB Funds AB | 158,032 | 237.4K SEK | 0.00 % | as of Mar 31, 2026 ↗ |
| Storebrand Sverige Plus Storebrand Asset Management AS | 84,000 | 126.2K SEK | 0.00 % | as of Mar 31, 2026 ↗ |
| World xFund Allocation Nowo Fund Management AB | 35,000 | 52.6K SEK | 2.05 % | as of Mar 31, 2026 ↗ |
| Skandia Sverige Exponering Skandia Fonder AB | 24,507 | 36.8K SEK | 0.00 % | as of Mar 31, 2026 ↗ |
| Storebrand Sverige Småbolag Plus Storebrand Asset Management AS | 21,000 | 31.5K SEK | 0.00 % | as of Mar 31, 2026 ↗ |
| PLUS Hälsovård Sverige Index ISEC Services AB | 15,710 | 23.6K SEK | 0.04 % | as of Mar 31, 2026 ↗ |
| Småbolag Sverige Exponering Skandia Fonder AB | 6,466 | 9.7K SEK | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| World xFund Allocation Nowo Fund Management AB | 2.05 % | as of Mar 31, 2026 ↗ |
| PLUS Mikrobolag Sverige Index ISEC Services AB | 0.09 % | as of Mar 31, 2026 ↗ |
| PLUS Hälsovård Sverige Index ISEC Services AB | 0.04 % | as of Mar 31, 2026 ↗ |
| Småbolag Sverige Exponering Skandia Fonder AB | 0.00 % | as of Mar 31, 2026 ↗ |
| Handelsbanken Sverige Index Criteria Handelsbanken Fonder AB | 0.00 % | as of Mar 31, 2026 ↗ |
| SEB Sverige Indexfond SEB Funds AB | 0.00 % | as of Mar 31, 2026 ↗ |
| Storebrand Sverige Småbolag Plus Storebrand Asset Management AS | 0.00 % | as of Mar 31, 2026 ↗ |
| SEB Sverige Indexnära SEB Funds AB | 0.00 % | as of Mar 31, 2026 ↗ |
| Storebrand Sverige Plus Storebrand Asset Management AS | 0.00 % | as of Mar 31, 2026 ↗ |
| Skandia Sverige Exponering Skandia Fonder AB | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2025Q4 | 1 | 0 | 1,822 | -1.4 % |
| 2025Q3 | 1 | 0 | 1,848 | -41.1 % |
| 2025Q2 | 1 | 0 | 3,135 | +66.1 % |
| 2025Q1 | 1 | 0 | 1,887 | +40.7 % |
| 2024Q4 | 1 | 0 | 1,341 | +45.0 % |
| 2024Q3 | 1 | 0 | 925 | +9.2 % |
| 2024Q2 | 1 | 0 | 847 | +12.0 % |
| 2024Q1 | 1 | -1 | 756 | -99.1 % |
| 2023Q4 | 2 | 83,159 |
Cite this page
Titelia. "Fund shareholders of IRLAB Therapeutics AB". https://titelia.com/en/stocks/irlab-therapeutics-ab-SE0012675361